General Information
BounceWatch is an independent company data service, not affiliated with Astex Pharmaceuticals . To contact Astex Pharmaceuticals , visit astx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Astex Pharmaceuticals compare?
A PDF of Astex Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Astex Pharmaceuticals soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Astex Pharmaceuticals on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United Kingdom Market
Biotechnology
About Astex Pharmaceuticals
Business keywords: Pharmaceuticals, Drug Discovery, Cancer Research, CNS Disorders, Innovative Technology, Oncology Drugs, Clinical Development, Scientific Research, Fragment-Based Drug Discovery, Cambridge, UK, Collaborations, Industrial Environment, Scientists, Small Molecule Therapeutics
No funding data available for Astex Pharmaceuticals yet.
Astex Pharmaceuticals Alternatives & Competitors
View All AlternativesWe develop and apply fragment and structure-based methods to solve problems in drug discovery
Mission Therapeutics is a private, drug discovery and development company focused on selectively tar...
Myro’s mission is to develop first-in-class and best-in-class small molecule drugs for CNS disorders...
FAQ About Astex Pharmaceuticals
Source: BounceWatch company record for Astex Pharmaceuticals , https://bouncewatch.com/company/astex-pharmaceuticals, updated 27 October 2024. When citing, please name BounceWatch and link this page.